PayPal Holdings Inc (2PP)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 51.23 |
|---|---|
| 52-week range | 32.74 – 70.55 |
| Return, 1 month / 3 months | +10.9% / +5.0% |
| Return, 1 year / 3 years | −12.3% / +2.7% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 43.4% |
| Worst drawdown (1 year) | -50.1% |
| Average daily value traded | 0.93M EUR |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PayPal Holdings operates a digital payments platform that lets people and businesses send and receive money online and through mobile devices. Its services include online checkout, peer-to-peer transfers, and payment processing for merchants, offered under brands such as PayPal, Braintree, Venmo and Xoom. Customers range from individual consumers to small businesses and large online retailers. The company is based in San Jose, California, and serves users in many countries around the world.
PayPal Holdings Inc trades under the code 2PP on the XETRA Stock Exchange in Germany, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PayPal Holdings Inc (2PP) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 51.23 on 23 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 364 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.3% and over the last three months it rose 5.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 75 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.6% | ||
| From 52-week high | -22.1% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.0% | ||
| 6-month return | 21.0% | ||
| 12-month return, skipping the last month | -21.0% | ||
| Stability (higher is calmer) | 26 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 43.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -50.1% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 0.93M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 11 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.1% |
|---|---|
| 1 month | +10.9% |
| 3 months | +5.0% |
| 6 months | +21.0% |
| 1 year | −12.3% |
| 3 years | +2.7% |
| 5 years | −75.0% |
Signals
| 50-day / 200-day average | 48.71 / 42.84 |
|---|---|
| Golden / death cross (60 days) | Golden, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Sep 2026 | USD 0.1245 |
| 4 Jun 2026 | USD 0.1245 |
| 4 Mar 2026 | USD 0.1245 |
| 19 Nov 2025 | USD 0.1245 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.